Profiling Extracellular Vesicle Proteome of Small Cell Lung Cancer Patients for Non-Invasive Subtyping and Monitoring
Small cell lung cancer (SCLC) is a highly aggressive form of cancer, characterized by a particularly poor prognosis. Subsequently, it has a very low five-year survival rate of only 6%. At the clinic, patients are either diagnosed at advanced stages where care is more palliative and with few therapeutic options or, when diagnosed at earlier stages, respond very positively to first-line treatments b
